David Scott Miller


AuthID: R-00K-250

Confirmed Publications: 317



101
TITLE: Phase III trial: Adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel/ carboplatin in high-intermediate and high-risk early stage endometrial cancer
AUTHORS: Marcus E Randall; Virginia Filiaci; Scott S McMeekin; Vivian Von Gruenigen; Helen Huang; Catheryn M Yashar; Robert S Mannel; Jae Weon Kim; Ritu Salani; Paul A DiSilvestro; James J Burke; Thomas Rutherford; Nick M Spirtos; Keith Terada; Penny R Anderson; Wendy R Brewster; William Small; Carol A Aghajanian; David Scott Miller ;
PUBLISHED: 2019, SOURCE: Journal of Clinical Oncology, VOLUME: 37, ISSUE: 21
INDEXED IN: Scopus CrossRef: 246
IN MY: ORCID | CIÊNCIAVITAE
102
TITLE: Reply to F. Tomao et al
AUTHORS: Martee L Hensley; Danielle Enserro; David Scott Miller ;
PUBLISHED: 2019, SOURCE: Journal of Clinical Oncology, VOLUME: 37, ISSUE: 11
INDEXED IN: Scopus CrossRef
IN MY: ORCID | CIÊNCIAVITAE
103
TITLE: Sex hormone, insulin, and insulin-like growth factor signaling in recurrence of high stage endometrial cancer: Results from the NRG Oncology/Gynecologic Oncology Group 210 trial.
AUTHORS: Gloria S Huang; Melissa A Merritt; Alan Hutson; Howard D Strickler; Mark Einstein; Jurriaan Brouwer-Visser; Nilsa C Ramirez; Heather A Lankes; Mona El-Bahrawy; Xiaonan Xue; Herbert Yu; Robert S Mannel; David M O'Malley; David Gardner Mutch; Paul Disilvestro; Melissa Ann Geller; Saketh R Guntupalli; Michael J Birrer; David Scott Miller ; Marc J Gunter;
PUBLISHED: 2019, SOURCE: Journal of Clinical Oncology, VOLUME: 37, ISSUE: 15_suppl
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
104
105
TITLE: Adenocarcinoma of the uterine corpus
AUTHORS: William T Creasman; David Scott Miller ;
PUBLISHED: 2018, SOURCE: Clinical Gynecologic Oncology
INDEXED IN: Scopus CrossRef: 1
IN MY: ORCID | CIÊNCIAVITAE
106
TITLE: Adjuvant external radiation impacts outcome of pelvis-limited stage III endometrial carcinoma: A multi-institutional study. A Multi-institutional Study
AUTHORS: Kevin Albuquerque; Michael Folkert; Jyoti Mayadev; Alana Christie; Margaret R Liotta; Christa Nagel; Parag Sevak; Matthew M Harkenrider; Jayanthi S Lea; Rabbie K Hanna; William C Small; David Scott Miller ; Xian Jin Xie; Ronald K Potkul; Mohamed A Elshaikh;
PUBLISHED: 2018, SOURCE: American Journal of Clinical Oncology: Cancer Clinical Trials, VOLUME: 41, ISSUE: 8
INDEXED IN: Scopus CrossRef: 7
IN MY: ORCID | CIÊNCIAVITAE
107
TITLE: Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: A phase III NRG oncology/gynecologic oncology group study
AUTHORS: Martee L Hensley; Danielle Enserro; Helen Hatcher; Petronella B Ottevanger; Anders Krarup Hansen; Jean Yves Blay; Cyril Fisher; Katherine M Moxley; Shashikant B Lele; Jayanthi S Lea; Krishnansu S Tewari; Premal H Thaker; Oliver Zivanovic; David M O'Malley; Katina Robison; David Scott Miller ;
PUBLISHED: 2018, SOURCE: Journal of Clinical Oncology, VOLUME: 36, ISSUE: 33
INDEXED IN: Scopus CrossRef: 58
IN MY: ORCID | CIÊNCIAVITAE
108
TITLE: Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for uterus-limited, high-grade leiomyosarcoma: A phase III GOG study.
AUTHORS: Martee Leigh Hensley; Danielle Enserro; Helen Hatcher; Ottevanger, PB; Anders Krarup-Hansen; Jean-Yves Blay; Cyril Fisher; Katherine M Moxley; Shashikant B Lele; Jayanthi Sivasothy Lea; Krishnansu Sujata Tewari; Premal H Thaker; Oliver Zivanovic; David M O'Malley; Katina Robison; David Scott Miller ;
PUBLISHED: 2018, SOURCE: Journal of Clinical Oncology, VOLUME: 36, ISSUE: 15_suppl
INDEXED IN: CrossRef: 5
IN MY: ORCID | CIÊNCIAVITAE
109
TITLE: An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer  Full Text
AUTHORS: Casey M Cosgrove; David L Tritchler; David E Cohn; David G Mutch; Craig M Rush; Heather A Lankes; William T Creasman; David Scott Miller ; Nilsa C Ramirez; Melissa A Geller; Matthew A Powell; Floor J Backes; Lisa M Landrum; Cynthia Timmers; Adrian A Suarez; Richard J Zaino; Michael L Pearl; Paul A DiSilvestro; Shashikant B Lele; Paul J Goodfellow;
PUBLISHED: 2018, SOURCE: Gynecologic Oncology, VOLUME: 148, ISSUE: 1
INDEXED IN: Scopus CrossRef: 88
IN MY: ORCID | CIÊNCIAVITAE
110
TITLE: Analysis of patient-reported outcomes (PROs) for GOG-258, a randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel (Cis-RT+CP) vs. carboplatin and paclitaxel (CP) for optimally debulked, locally advanced endometrial carcinoma: A Gynecologic Oncology Group/NRG study.
AUTHORS: Ursula A Matulonis; Virginia L Filiaci; Helen Q Huang; Marcus Randall; Byoung Kim; Paul DiSilvestro; Katherine M Moxley; David M O'Malley; Matthew A Powell; Nicola M Spirtos; Krishnansu Sujata Tewari; William Richards; John Nakayama; Margaret Steinhoff; David Gardner Mutch; David Scott Miller ; Lari B Wenzel; Daniela Matei;
PUBLISHED: 2018, SOURCE: Journal of Clinical Oncology, VOLUME: 36, ISSUE: 15_suppl
INDEXED IN: CrossRef: 4
IN MY: ORCID | CIÊNCIAVITAE
Page 11 of 32. Total results: 317.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service